Merck osteoporosis drug passes trial, but side effects hover

[riky]

Merck osteoporosis drug passes trial, but side effects hover

By Ransdell Pierson (Reuters) - Merck & Co said it will seek U.S. approval next year for its long-delayed experimental osteoporosis drug, odanacatib, after it proved effective in a late-stage trial but was associated with rare thigh-bone fractures seen with standard treatments. The once-weekly pill, deemed a potential blockbuster product by some industry analysts, significantly reduced risk of fractures of the hip and spine, and of non-vertebral fractures, compared with placebo, Merck said on Monday. ...

Source: You are not allowed to view links. Register or Login